Blue Cone Monochromacy (BCM)

Blue cone monochromacy (BCM) is a very rare eye disease that a person is born with. In this condition, the red and green cone cells in the retina do not work, or work only a little. Only the blue cone cells and the rod cells work well. Because of this, the person sees poorly, has serious color vision problems, and is very sensitive to bright light. [1] BCM is passed down in families in an X-linked recessive way. This means the faulty gene is on the X chromosome. It mostly affects boys and men, because they have only one X chromosome. Girls and women usually carry the gene and may have mild or no symptoms, because they have two X chromosomes and the second copy can partly protect them. [2]

Blue cone monochromacy (BCM) is a rare genetic eye condition you are born with. In BCM, the “red” (L) and “green” (M) cone cells in the retina do not work well, or they do not work at all. That means the eye mainly depends on “blue” (S) cones and rod cells. Because cones help you see fine detail and color in bright light, many people with BCM have blurry vision, very poor red-green color vision, and strong discomfort in bright light (photophobia). Many people also have shaky eye movements (nystagmus) and short-sightedness (myopia). BCM usually happens because of changes in the OPN1LW/OPN1MW gene cluster on the X chromosome, so it mostly affects males. [BCM gene therapy review]

Blue cone monochromacy, also called BCM or sometimes X-linked incomplete achromatopsia, is a rare inherited eye disease in which the red-sensitive and green-sensitive cone cells do not work well, while the blue cones still work. Because of that, a person can have very poor color vision, low sharpness of sight, light sensitivity, nystagmus, and often myopia from early life. BCM is usually caused by changes in the OPN1LW/OPN1MW gene cluster on the X chromosome, and at present there is no FDA-approved cure that restores normal cone function. Current care is mostly supportive, with glasses, filters, low-vision help, symptom control, and regular follow-up, while gene therapy is still investigational.

In BCM, the sharpness of sight (visual acuity) is usually reduced to about 20/60 to 20/200. The person often cannot tell many colors apart and may see the world mainly in shades of blue and gray. Bright daylight is very uncomfortable, and moving eyes (nystagmus) and short-sightedness (myopia) are common. [3]

Another names of blue cone monochromacy

Doctors and researchers use several other names for this disease. These names can appear in older books or in medical reports. [4]

• X-linked achromatopsia – an older name that stressed that the disease is linked to the X chromosome and causes almost no color vision. [5]

• Blue cone monochromatism – another common form of the same name, using “monochromatism” instead of “monochromacy”. [6]

• S-cone monochromacy – used in some papers, because the S-cones (short-wavelength, “blue” cones) are the only cones that function well. [7]

• Atypical X-linked achromatopsia – used in the past when BCM was thought to be a special form of achromatopsia with a slightly different pattern. [8]

• X-linked incomplete achromatopsia – another old term that suggests some small remaining cone function. [9]

Types of blue cone monochromacy

Doctors sometimes group BCM into forms based on gene changes and how the eye looks over time. These “types” are not strict official classes but help describe patterns seen in patients. [10]

• Classic congenital blue cone monochromacy – symptoms start in early baby life and stay mostly stable over many years. The person always has low vision, very poor color sense, nystagmus, and light sensitivity. [11]

• Progressive blue cone monochromacy – in some people, tests show that cone function slowly gets worse with age. The center of the retina (macula) may become thinner or scarred later in life, so vision may slowly decline. [12]

• BCM with foveal hypoplasia – some patients have a fovea (the very center of the retina) that never developed fully. On eye scans, the normal foveal “pit” and layers are missing or blunted, and this adds to poor central vision. [13]

• Genotype-defined BCM subtypes – researchers also speak of types based on the exact gene problem, such as deletions of the locus control region, hybrid opsin genes, or specific point mutations. These subgroups help in research and gene therapy planning. [14]

Causes of blue cone monochromacy

BCM is caused by changes (mutations) in genes that control the red and green cone opsin proteins. Each “cause” below describes a different kind or pattern of gene change or inheritance. [15]

1. X-linked recessive inheritance – the main cause is that the faulty genes sit on the X chromosome. Males with one faulty copy show the disease, while females often carry one faulty copy and may be only mildly affected or not affected at all. [16]

2. Mutations in the OPN1LW gene (red cone opsin) – harmful changes in this gene stop the red cone pigment from working. This removes or greatly reduces signals from red cones so the eye loses one major color channel. [17]

3. Mutations in the OPN1MW gene (green cone opsin) – similar damaging changes in this gene stop the green cone pigment from working. With both red and green cone systems affected, only the blue cone system remains functional. [18]

4. Loss of function in both OPN1LW and OPN1MW together – BCM happens when gene changes make both pigments non-functional at the same time. This combined loss explains why color vision is so severely limited. [19]

5. Locus control region (LCR) deletions or defects – the LCR is a control switch that turns on the red and green opsin genes. Deletions or changes here can shut down both genes even if the genes themselves look normal, leading to BCM. [20]

6. Large gene deletions in the opsin gene cluster – some patients have big missing segments that remove one or both opsin genes. Without these genes, red and green cones never develop normal light-sensitive pigments. [21]

7. Hybrid opsin genes with inactivating changes – sometimes pieces of the red and green opsin genes mix and form hybrid genes. If these hybrids carry harmful amino-acid combinations, the resulting pigment does not work and causes BCM. [22]

8. Missense mutations in key amino acids – a missense mutation swaps one amino acid for another in the pigment protein. In certain positions, even a single swap can misfold the pigment so that the cone cell cannot use it. [23]

9. Nonsense mutations causing early stop codons – a nonsense mutation creates a “stop” signal too early in the gene. This leads to a short, incomplete protein that is quickly broken down, leaving the cone without a working pigment. [24]

10. Splice-site and intronic mutations – some mutations occur in non-coding or splice regions that control how the gene is cut and joined. Bad splicing makes faulty mRNA and can stop the pigment from being made correctly. [25]

11. Exon deletions (for example, exon 3 or 4 loss) – specific exons can be missing from the opsin gene. Without these sections, the protein loses important domains and becomes non-functional, causing cone failure. [26]

12. The LIAVA genotype and similar inactivating haplotypes – some combinations of amino acids, such as the LIAVA pattern in exon 3, make the pigment unable to function in real cone cells, even though it may respond in lab tests. [27]

13. Copy-number variations in the opsin gene array – people can have different numbers and orders of red and green opsin genes. Some copy-number patterns combined with harmful variants can produce BCM instead of simple red-green color blindness. [28]

14. Submicroscopic structural variants at the opsin locus – fine structural changes, such as small inversions or complex rearrangements near the opsin cluster, can disrupt gene control and lead to loss of cone function. [29]

15. De novo (new) mutations – in some families, a mutation arises in the egg or sperm for the first time. A boy may have BCM even if there is no previous family history, because the change is new in him. [30]

16. Carrier mothers passing on a faulty X chromosome – a mother who carries a faulty opsin gene on one X chromosome can pass this X to her son. If the son receives this X and a normal Y, he will have BCM. [31]

17. Inherited haplotypes that combine two harmful changes – in some cases, one gene copy has a deletion and the other has a point mutation. Together, these two different problems fully remove red and green cone function. [32]

18. In-frame deletions that alter protein folding – some mutations remove a few amino acids but keep the reading frame. These can disturb how the pigment folds or sits in the cone cell membrane, leading to loss of function. [33]

19. Promoter mutations that reduce gene expression – changes in the promoter regions of the opsin genes or the LCR can lower or stop gene expression. With little or no pigment made, red and green cones do not send useful signals. [34]

20. Combined genetic and environmental influences on retinal health – BCM itself is genetic, but other eye stresses, such as high myopia or light damage, may add extra strain on the already weak cone system, possibly worsening central retinal changes over time. [35]

Symptoms of blue cone monochromacy

1. Low visual acuity (blurry central vision) – people with BCM usually have blurry sight from early life. Even with glasses, they often cannot see small letters on a chart and may struggle to read normal print or see details at a distance. [36]

2. Severe color vision loss – most patients cannot tell many colors apart. Many colors look washed out or gray, and only a narrow range of blue shades may be seen clearly, because only blue cones and rods work well. [37]

3. Photophobia (light sensitivity) – bright daylight or indoor lights can feel painful or dazzling. Patients often squint, close their eyes, or avoid going outdoors in full sun and may prefer dim or shaded places. [38]

4. Hemeralopia (day-time visual difficulty) – vision can feel especially poor in bright conditions. Strong light can “wash out” the image, making it harder to see faces, signs, or school boards, even though night or dim-light vision is relatively better. [39]

5. Nystagmus (involuntary eye movements) – the eyes may move quickly and repeatedly, often from side to side. This usually starts in infancy. The shaking can make objects seem to move or jump and can further reduce clear central vision. [40]

6. Myopia (short-sightedness) – many people with BCM become short-sighted. They see better up close than far away and need glasses for distance tasks like reading the classroom board or seeing road signs. [41]

7. Reduced contrast sensitivity – it can be hard to see objects that do not stand out strongly from the background, for example gray text on a gray wall or pale print on white paper. This makes reading and mobility harder. [42]

8. Difficulty recognizing faces and details – because central vision is weak, it may be hard to see small differences in faces or objects. Children may stand very close to people or screens to see better. [43]

9. Problems with school or reading tasks – small print, bright white paper, and chalkboards or projectors can be hard to see. Children may tire quickly, read slowly, or avoid reading, which can be mistaken for learning problems. [44]

10. Poor depth and distance judgment – color and contrast help the brain judge depth. With BCM, these cues are weak, so stepping off curbs, playing ball sports, or judging distance for driving can be more difficult. [45]

11. Eye strain and headaches – trying to see small details or working in bright light for long periods may cause discomfort, eye strain, or headaches, especially without the right tinted lenses or visual aids. [46]

12. Slow adaptation to changes in lighting – moving quickly from dark to bright areas, or the opposite, may be uncomfortable. The eyes take longer to adjust, and vision can be temporarily worse during the change. [47]

13. Central retinal changes later in life – some older patients develop thinning or atrophy in the macula. This can slowly lower central vision even more and may show up on scans before the patient notices big changes. [48]

14. Mild symptoms in some female carriers – some women who carry the gene may notice mild color vision problems, slight light sensitivity, or subtle changes on eye tests, even if daily vision seems mostly normal. [49]

15. Psychosocial and emotional impact – difficulty seeing at school, at work, or in social situations can cause frustration, anxiety, or low confidence. Support, clear explanations, and reasonable adjustments can greatly help quality of life. [50]

Diagnostic tests for blue cone monochromacy

Diagnosis of BCM needs careful eye examination, special vision tests, electrical tests, imaging, and genetic tests. These help to confirm BCM and to tell it apart from other conditions like achromatopsia. [51]

Physical exam tests

1. Detailed medical and family history – the eye doctor asks about vision problems from birth, light sensitivity, color issues, and similar symptoms in relatives. A pattern of affected males with carrier females suggests an X-linked condition like BCM. [52]

2. Full eye examination with slit lamp and dilated pupils – the doctor checks the front and back of the eye. In many patients the retina looks nearly normal, especially when they are young, so normal-looking eyes with severe color problems raise suspicion of BCM. [53]

3. Visual acuity testing – reading letters or symbols on a chart measures how sharp the vision is. Most people with BCM have reduced acuity in both eyes, even with the best possible glasses correction. [54]

4. Ocular alignment and nystagmus assessment – the doctor watches how the eyes move and work together. The presence of early-onset nystagmus and no major squint, together with color vision loss, supports a diagnosis of cone dysfunction such as BCM. [55]

Manual psychophysical tests

5. Ishihara color plate test – this common book of colored dot patterns quickly shows red-green color defects. People with BCM usually perform very poorly, often missing almost all plates, which shows severe color loss. [56]

6. Farnsworth D-15 test – the patient arranges colored caps in order. In BCM, the pattern of mistakes is broad and not limited to just one color axis, showing that many color pathways are disturbed. [57]

7. Farnsworth-Munsell 100-Hue test – this longer test uses many colored caps to measure fine color discrimination. Patients with BCM usually show large total error scores, confirming very poor cone-mediated color vision. [58]

8. Goldmann kinetic perimetry (manual visual field test) – the examiner moves light targets from outside to inside the patient’s visual field. Visual fields in BCM are often fairly full, helping to separate BCM from diseases with large field loss. [59]

Lab and pathological / genetic tests

9. Genetic counseling and pedigree drawing – a genetics specialist reviews the family tree to look for an X-linked pattern, discusses inheritance risks, and explains testing options. This is important before and after molecular tests. [60]

10. Targeted sequencing of OPN1LW and OPN1MW genes – lab tests read the DNA code of the red and green opsin genes. Finding harmful mutations in both confirms the molecular cause of BCM in many patients. [61]

11. Locus control region (LCR) deletion / duplication analysis – special tests such as MLPA or array methods look for missing or extra pieces in the LCR and nearby opsin gene cluster. This can detect structural changes that simple sequencing may miss. [62]

12. Expanded retinal gene panel or exome sequencing – if initial tests are negative or unclear, a broader panel checks many eye genes. This helps rule out other inherited cone or cone-rod disorders that can mimic BCM. [63]

Electrodiagnostic tests

13. Full-field electroretinography (ERG) – ERG measures the electrical response of the retina to light. In BCM, standard cone responses and 30-Hz flicker responses are greatly reduced or absent, while rod responses are usually near normal. [64]

14. 30-Hz flicker ERG – this specific cone-driven test uses fast repeated flashes. Patients with BCM show very small or no 30-Hz responses, confirming a major loss of L/M cone function. [65]

15. S-cone–isolating ERG – special blue flashes on bright yellow backgrounds can isolate the S-cone response. In BCM, this S-cone ERG is preserved or even relatively strong, while red and green cone responses are missing. [66]

16. Pattern visual evoked potentials (VEP) – VEPs record electrical signals from the brain while the patient looks at changing patterns. In BCM, VEPs may show reduced central vision function but can help exclude other optic nerve or brain problems. [67]

Imaging tests

17. Color fundus photography – photographs of the retina often look nearly normal in childhood but may later show subtle changes near the macula. Serial photos over time can reveal any slowly developing central atrophy. [68]

18. Spectral-domain optical coherence tomography (OCT) – OCT gives cross-section “slices” of the retina. In BCM, OCT can show thinning or disruption of the cone layer in the fovea, and in some patients foveal hypoplasia or later macular atrophy. [69]

19. Fundus autofluorescence imaging – this imaging looks at natural signals from retinal pigment. Patterns of reduced or increased autofluorescence near the macula may indicate stressed or damaged cone cells in BCM. [70]

20. Adaptive optics or high-resolution retinal imaging – in research settings, advanced cameras can show individual cone cells. In BCM, these images reveal a marked loss or abnormal pattern of red and green cones, with more preserved blue cones and rods. [71]

Non-pharmacological treatments (therapies + others)

1. Precision glasses / contact correction (best refraction)
   Description (simple): Many people with BCM have myopia and astigmatism. A careful eye exam and the best prescription can improve clarity more than people expect. Children often need updates as they grow.
   Purpose: Make the clearest image possible for reading and school.
   Mechanism: Corrects how light focuses on the retina so the remaining vision works better. [Cone dysfunction syndromes review]

2. Tinted lenses for photophobia (including FL-41 or custom filters)
   Description: Tinted lenses can reduce glare, reduce pain from bright light, and improve comfort outdoors and under strong indoor lights. Some people do better with specific wavelengths filtered. Trial and error with a low-vision clinic is helpful.
   Purpose: Reduce light sensitivity and improve day function.
   Mechanism: Reduces harsh light reaching the retina and can improve contrast by cutting “scatter.” [Tinted lenses photophobia]

3. Wraparound sunglasses + side shields + hats
   Description: Wraparound frames and side shields block light coming from the sides. A cap or wide-brim hat adds a simple “roof” that can strongly reduce glare outdoors.
   Purpose: Comfort, safety, and less squinting.
   Mechanism: Lowers total light and reflections entering the eye. [Tinted lens therapeutic review]

4. Low-vision rehabilitation (training + tools)
   Description: A low-vision specialist can teach practical skills: choosing fonts, using contrast, scanning text, and setting up a phone/computer for easier reading. This is a core treatment for BCM because it improves real-life function even when vision cannot be “fixed.”
   Purpose: Better daily independence.
   Mechanism: Uses the brain’s learning + assistive strategies to reduce visual load. [Vision rehabilitation practice PDF]

5. Optical magnifiers (handheld, stand, and high-add readers)
   Description: Magnifiers help with books, labels, and homework. Stand magnifiers reduce hand shaking. High-add reading glasses can be useful for close work at a short distance.
   Purpose: Make print bigger and easier.
   Mechanism: Enlarges the image so the retina can resolve it better. [Vision rehabilitation practice PDF]

6. Electronic magnification (CCTV, tablet/phone zoom, e-readers)
   Description: Tablets and phones can zoom, increase contrast, and invert colors. Video magnifiers (desktop or portable) are very helpful for schoolwork.
   Purpose: Reading access and study speed.
   Mechanism: Digital enlargement + contrast control matches the user’s best settings. [Vision rehabilitation practice PDF]

7. Large-print + high-contrast environment design
   Description: Use bold markers, thick lines, good contrast (black on white), and avoid “busy” patterns. Label items with large print. Keep consistent organization at home.
   Purpose: Fewer errors and faster finding.
   Mechanism: Contrast is easier for low vision than fine color differences. [Vision rehabilitation practice PDF]

8. Lighting control (not just “more light”)
   Description: Many BCM users do better with controlled light, not bright light. Use blinds, indirect lamps, anti-glare bulbs, and position lights behind you for reading but not shining into your eyes.
   Purpose: Reduce glare while keeping usable light for tasks.
   Mechanism: Less scatter and less photophobia trigger. [Tinted lenses therapeutic review]

9. Screen adaptations (dark mode, font size, cursor size, color themes)
   Description: Simple settings can reduce discomfort: larger fonts, lower brightness, night-shift, and dark mode. Some people prefer specific background colors.
   Purpose: Comfortable study and longer screen time without pain.
   Mechanism: Reduces light intensity and improves text-background separation. [Vision rehabilitation practice PDF]

10. Seating and classroom adjustments
    Description: Sit near the board, use printed notes, and ask for digital materials early. Extra time for exams can be needed because reading is slower.
    Purpose: School success and reduced stress.
    Mechanism: Removes the “distance-vision” burden and supports magnification tools. [Vision rehabilitation practice PDF]

11. Orientation & mobility training (if needed)
    Description: If glare and reduced acuity affect safe travel, training can help with street crossing, scanning, and safe movement in bright environments.
    Purpose: Safety and independence.
    Mechanism: Builds scanning habits and safer routes that reduce glare exposure. [Vision rehabilitation practice PDF]

12. Color-label systems (not color-dependent)
    Description: Because color discrimination is limited, use text labels, shapes, or position-based systems (for clothes, wires, school files).
    Purpose: Reduce daily mistakes.
    Mechanism: Replaces color decisions with reliable cues. [BCM gene therapy review]

13. Sports and activity adaptation (glare-safe choices)
    Description: Choose activities with lower glare (indoor, evening, shaded). Use sports eyewear with safe tints.
    Purpose: Keep active safely.
    Mechanism: Lowers glare triggers and improves contrast. [Tinted lenses photophobia]

14. Driving guidance (legal + safety counseling)
    Description: Many people with BCM do not meet legal driving vision standards, especially in bright daylight glare. A clinician can guide safe alternatives and local legal requirements.
    Purpose: Safety for the person and others.
    Mechanism: Prevents high-risk situations where acuity + glare make hazards hard to detect. [Cone dysfunction syndromes review]

15. Regular eye monitoring (retina + refraction)
    Description: Even if BCM is stable, checkups can catch treatable problems (dry eye, infections, inflammation, refractive changes). Some people can develop macular changes that need monitoring.
    Purpose: Protect vision and comfort long-term.
    Mechanism: Early detection of “extra problems” that worsen vision. [PLOS BCM visual function]

16. Genetic counseling and family planning support
    Description: BCM is commonly X-linked. Genetic counseling helps families understand who may be affected and what testing means.
    Purpose: Clear family risk understanding.
    Mechanism: Uses genetic inheritance patterns + testing to inform decisions. [BCM gene therapy review]

17. Psychological support (coping skills)
    Description: Long-term light sensitivity and school challenges can cause stress. Counseling or peer support groups can help with confidence and planning.
    Purpose: Better quality of life.
    Mechanism: Reduces anxiety, improves coping routines, and supports consistent tool use. [BCM Families info]

18. Assistive tech: OCR, text-to-speech, audiobooks
    Description: Phone OCR can read printed text out loud. Text-to-speech helps with long reading.
    Purpose: Reduce eye strain and study faster.
    Mechanism: Moves part of “visual reading” into audio processing. [Vision rehabilitation practice PDF]

19. Workplace accommodations (task redesign)
    Description: Use larger monitors, anti-glare filters, flexible lighting, and role adjustments that reduce fine color tasks.
    Purpose: Keep productivity and reduce fatigue.
    Mechanism: Matches tasks to visual strengths (contrast + magnification). [Vision rehabilitation practice PDF]

20. Clinical trial awareness (investigational gene therapy / gene editing)
    Description: BCM is a target for gene-based treatments in research. Trials change over time, so a retina specialist can help you check eligibility and risks/benefits.
    Purpose: Access to future treatments (research).
    Mechanism: Attempts to restore or improve cone pathway using gene delivery/editing (still investigational). [ClinicalTrials.gov BCM listing]

---

Drug treatments

There is no FDA-approved drug that cures BCM or restores the missing red/green cone function right now. Medicines are used only to treat related symptoms or other eye problems (dry eye, allergies, inflammation, infections) that can happen in anyone and can feel worse when you already have low vision. The drug choices below are examples your eye doctor may consider if you have those problems, and they come from FDA labeling documents. [RESTASIS label]

1) Cyclosporine ophthalmic emulsion 0.05% (RESTASIS)

Long description: This drop is used for chronic dry eye when tear production is low because of inflammation on the eye surface. It is not a painkiller and it does not fix BCM, but it can make eyes feel less dry and less irritated over time. It often takes weeks to months to notice full benefit.
Class: Calcineurin-inhibitor immunomodulator.
Dosage / Time: 1 drop in each eye twice daily about 12 hours apart.
Purpose: Increase tear production in inflammatory dry eye.
Mechanism: Reduces inflammatory signaling that suppresses tears.
Side effects: Burning/stinging, redness, watery eyes. [RESTASIS label]

2) Lifitegrast ophthalmic solution 5% (XIIDRA)

Long description: Lifitegrast treats signs and symptoms of dry eye disease. It can help some people with dryness discomfort that makes light sensitivity feel worse. It does not change BCM genetics, but it may improve comfort and reading stamina.
Class: LFA-1 antagonist (anti-inflammatory for dry eye).
Dosage / Time: 1 drop in each eye twice daily, about 12 hours apart; remove contacts before use and reinsert later (per label).
Purpose: Dry eye symptom relief.
Mechanism: Blocks interaction that drives inflammation on the ocular surface.
Side effects: Eye irritation, unusual taste (dysgeusia), blurred vision. [XIIDRA label]

3) Loteprednol etabonate 0.25% (EYSUVIS)

Long description: This is a steroid drop used for short courses when dry eye flares include inflammation. It can calm redness and irritation. It must be used carefully because steroids can raise eye pressure in some people.
Class: Corticosteroid.
Dosage / Time: Short-term use as directed by an eye doctor (label is for short-term treatment of dry eye flares).
Purpose: Reduce inflammatory flare signs.
Mechanism: Steroids reduce inflammatory mediators and swelling.
Side effects: Increased eye pressure, cataract risk with longer use, infection risk. [EYSUVIS label]

4) Loteprednol etabonate 0.5% gel (LOTEMAX gel)

Long description: Another steroid option, often used after surgery or for inflammation. For BCM, it is only relevant if you have a separate inflammatory eye condition.
Class: Corticosteroid.
Dosage / Time: As prescribed; typically short courses for inflammation.
Purpose: Calm steroid-responsive inflammation.
Mechanism: Suppresses inflammatory response pathways.
Side effects: Eye pressure rise, cataract risk with prolonged use, delayed healing. [LOTEMAX label]

5) Prednisolone acetate 1% (PRED FORTE)

Long description: A stronger steroid used for steroid-responsive inflammation of the front of the eye. It is not for BCM itself. It is used when a doctor finds inflammation that needs treatment.
Class: Corticosteroid.
Dosage / Time: Individualized; can be frequent at first then taper.
Purpose: Control inflammation.
Mechanism: Decreases inflammatory cell activity and mediators.
Side effects: Raised eye pressure, cataract with prolonged use, infection risk. [PRED FORTE label]

6) Ketorolac 0.5% ophthalmic (ACULAR)

Long description: This NSAID eye drop is used for itching from seasonal allergy and for inflammation after cataract surgery. It may help if itching or inflammation adds discomfort on top of BCM.
Class: NSAID.
Dosage / Time: Often 1 drop 4 times daily for labeled uses (doctor-directed).
Purpose: Reduce itch/inflammation.
Mechanism: Blocks prostaglandin production.
Side effects: Burning/stinging, delayed healing in some cases. [ACULAR label]

7) Bromfenac ophthalmic (PROLENSA)

Long description: An NSAID used mainly after cataract surgery to reduce inflammation and pain. Included here because people with BCM can still need cataract care later in life.
Class: NSAID.
Dosage / Time: Once daily dosing around cataract surgery (label-guided).
Purpose: Post-op inflammation and pain.
Mechanism: Prostaglandin inhibition.
Side effects: Eye irritation; corneal risks in susceptible patients. [PROLENSA label]

8) Nepafenac ophthalmic suspension 0.3% (ILEVRO)

Long description: Another NSAID for pain and inflammation with cataract surgery. It does not treat BCM, but it may be used if cataract surgery occurs.
Class: NSAID.
Dosage / Time: Once daily around surgery per label.
Purpose: Post-surgery pain/inflammation control.
Mechanism: Prodrug converted to active NSAID in the eye, reducing prostaglandins.
Side effects: Eye irritation; delayed healing risk. [ILEVRO label]

9) Olopatadine ophthalmic (PATADAY)

Long description: Allergy itch can be very distracting for a low-vision person. This antihistamine/mast-cell stabilizer helps ocular itching from allergic conjunctivitis.
Class: Antihistamine / mast-cell stabilizer.
Dosage / Time: Once daily per product labeling (varies by strength).
Purpose: Reduce allergy itching.
Mechanism: Blocks histamine effects and reduces allergic mediator release.
Side effects: Mild burning, dryness, headache in some. [PATADAY label]

10) Moxifloxacin ophthalmic solution 0.5% (VIGAMOX)

Long description: Antibiotic drops treat bacterial eye infections. If an infection happens, treating quickly protects comfort and prevents extra vision loss.
Class: Fluoroquinolone antibiotic.
Dosage / Time: Doctor-directed for infection; label warns it is for topical use only.
Purpose: Treat bacterial conjunctivitis/ocular infection when indicated.
Mechanism: Inhibits bacterial DNA enzymes needed for replication.
Side effects: Irritation, allergy reactions in sensitive people. [VIGAMOX label]

11) Ofloxacin ophthalmic solution 0.3% (OCUFLOX)

Long description: Another antibiotic option for susceptible bacterial infections of the eye.
Class: Fluoroquinolone antibiotic.
Dosage / Time: Doctor-directed based on infection type.
Purpose: Treat bacterial infection.
Mechanism: Blocks bacterial DNA replication enzymes.
Side effects: Burning, discomfort, possible hypersensitivity. [OCUFLOX label]

12) Gatifloxacin ophthalmic 0.5% (ZYMAXID)

Long description: Used for bacterial conjunctivitis. It is an option when a doctor suspects bacterial infection and chooses this agent.
Class: Fluoroquinolone antibiotic.
Dosage / Time: Day 1 can be frequent; then less frequent for days 2–7 (per label schedule).
Purpose: Treat bacterial conjunctivitis.
Mechanism: Stops bacterial DNA replication enzymes.
Side effects: Eye irritation, taste issues, headache in some reports. [ZYMAXID label]

13) Besifloxacin ophthalmic 0.6% (BESIVANCE)

Long description: A suspension used for bacterial conjunctivitis. Helpful when bacterial infection is confirmed or strongly suspected.
Class: Fluoroquinolone antibiotic.
Dosage / Time: 1 drop 3 times daily for 7 days (per label).
Purpose: Treat bacterial conjunctivitis.
Mechanism: Inhibits bacterial DNA processes needed for growth.
Side effects: Redness, blurred vision, irritation. [BESIVANCE label]

14) Polymyxin B + trimethoprim ophthalmic (POLYTRIM)

Long description: This combination antibiotic drop is used for external bacterial eye infections. It is often used in common conjunctivitis cases when the clinician chooses it.
Class: Combination antibiotic.
Dosage / Time: Doctor-directed depending on infection severity.
Purpose: Treat bacterial infection.
Mechanism: Polymyxin disrupts bacterial membranes; trimethoprim blocks folate pathway.
Side effects: Local irritation, allergy. [POLYTRIM label]

15) Tobramycin ophthalmic ointment 0.3% (TOBREX ointment)

Long description: An antibiotic ointment used for external eye infections. Ointment can be useful at night because it stays longer, but it blurs vision temporarily.
Class: Aminoglycoside antibiotic.
Dosage / Time: Doctor-directed.
Purpose: Treat susceptible bacterial infections.
Mechanism: Blocks bacterial protein synthesis.
Side effects: Burning, swelling, allergy. [TOBREX label]

16) Azithromycin ophthalmic solution 1% (AZASITE)

Long description: Used for some bacterial conjunctivitis cases and sometimes for eyelid gland inflammation (doctor choice). It does not treat BCM but may treat related surface disease.
Class: Macrolide antibiotic.
Dosage / Time: Label-based schedules vary by indication and clinician.
Purpose: Treat bacterial eye infection when chosen.
Mechanism: Inhibits bacterial protein synthesis.
Side effects: Eye irritation, blurred vision, bitter taste. [AZASITE label]

17) Tobramycin + dexamethasone (TOBRADEX)

Long description: This combines an antibiotic with a steroid. It is used when a doctor believes there is inflammation and a risk of bacterial infection together. Steroid risks still apply.
Class: Antibiotic + corticosteroid combination.
Dosage / Time: Doctor-directed; short-term use is common.
Purpose: Treat inflammation with infection coverage.
Mechanism: Antibiotic kills bacteria; steroid suppresses inflammation.
Side effects: Eye pressure rise, cataract risk with prolonged use, infection masking. [TOBRADEX label]

18) Sulfacetamide sodium ophthalmic solution (example 30%)

Long description: An older antibiotic option for conjunctivitis and related infections, used when susceptible organisms and clinical judgment support it.
Class: Sulfonamide antibiotic.
Dosage / Time: Doctor-directed.
Purpose: Treat bacterial conjunctivitis or corneal ulcer cases when appropriate.
Mechanism: Blocks bacterial folate synthesis.
Side effects: Stinging, allergy reactions (sulfa sensitivity). [Sulfacetamide ophthalmic approval]

19) Neomycin + polymyxin B + dexamethasone (MAXITROL suspension)

Long description: Another antibiotic + steroid combination used in certain inflammatory eye conditions where infection risk exists. It must be avoided in some viral/fungal situations, so it requires diagnosis first.
Class: Antibiotics + corticosteroid.
Dosage / Time: Doctor-directed.
Purpose: Reduce inflammation while covering bacteria.
Mechanism: Steroid suppresses inflammation; antibiotics inhibit bacteria.
Side effects: Increased eye pressure, delayed healing, allergy, infection risk. [MAXITROL label]

20) Neomycin + polymyxin B + bacitracin ophthalmic ointment (NEOSPORIN ophthalmic ointment)

Long description: A multi-antibiotic ointment used for certain external infections. Ointment can be useful at bedtime but blurs vision.
Class: Combination antibiotic ointment.
Dosage / Time: Doctor-directed.
Purpose: Treat external bacterial infections.
Mechanism: Each antibiotic targets bacteria in a different way, improving coverage.
Side effects: Allergy (neomycin sensitivity is possible), irritation. [NEOSPORIN ophthalmic ointment label]

---

Dietary molecular supplements (supportive, not a BCM cure)

Supplements cannot fix the gene cause of BCM. Still, some nutrients support general eye tissue health, and some are studied in other retinal diseases. Always ask a clinician before high doses, especially if you take other medicines. [NCCIH eye supplements science]

1) Lutein

Long description: Lutein is a carotenoid that can accumulate in the retina (macula). It is often discussed for macular support and light filtering. For BCM, evidence is indirect (not BCM-specific), but some people use it as part of “retina health” habits.
Dosage: Common supplement doses are often in the 10 mg/day range in studies (example from AREDS2 context).
Function: Supports macular pigment.
Mechanism: Acts as a light filter and antioxidant in retinal tissue. [Retina lutein/zeaxanthin review]

2) Zeaxanthin

Long description: Zeaxanthin is similar to lutein and is part of macular pigment. Like lutein, BCM evidence is indirect, but it is commonly used for general macular support.
Dosage: Often 2 mg/day in AREDS2 formulation examples.
Function: Macular pigment support.
Mechanism: Antioxidant + blue-light filtering properties in the macula. [NEI AREDS/AREDS2 info]

3) Vitamin A (avoid megadoses unless prescribed)

Long description: Vitamin A is essential for normal vision chemistry (especially in rods). Deficiency harms the cornea and vision. But too much vitamin A can be toxic, so high-dose self-treatment is unsafe.
Dosage: Meet recommended intake unless a clinician treats deficiency.
Function: Supports normal eye surface and retinal chemistry.
Mechanism: Needed for visual pigments and healthy eye tissues. [NIH ODS Vitamin A fact sheet]

4) Vitamin C

Long description: Vitamin C is an antioxidant used in many eye supplement formulas for oxidative stress support. BCM-specific proof is not established, but vitamin C helps general tissue repair and antioxidant balance.
Dosage: Common supplemental doses vary; avoid extreme dosing without medical advice.
Function: Antioxidant support.
Mechanism: Helps neutralize oxidative molecules that can damage cells. [NEI AREDS/AREDS2 info]

5) Vitamin E

Long description: Vitamin E is another antioxidant used in major eye study formulas (for AMD, not BCM). It is included here as a general antioxidant option, not as a BCM treatment.
Dosage: Varies; discuss if you use blood-thinners.
Function: Antioxidant protection.
Mechanism: Helps protect cell membranes from oxidative injury. [NEI AREDS/AREDS2 info]

6) Zinc (with copper when appropriate)

Long description: Zinc supports many enzymes and is part of some eye supplement formulas. Too much zinc can upset the stomach and affect copper balance, so balanced formulas matter.
Dosage: Follow reputable formulations; avoid “mega zinc” long-term without supervision.
Function: Enzyme and retinal support.
Mechanism: Supports antioxidant enzyme systems and cell functions. [NEI AREDS/AREDS2 info]

7) Copper

Long description: Copper is often added to balance zinc in some eye formulas. It is not a BCM treatment, but it prevents copper deficiency when zinc intake is high.
Dosage: Usually small amounts in balanced formulas.
Function: Mineral balance.
Mechanism: Supports blood and enzyme function; balances zinc effects. [NEI AREDS/AREDS2 info]

8) Omega-3 (EPA/DHA)

Long description: Omega-3 oils are used for dry eye by some people. Research results are mixed: some reviews find little benefit, and some find small improvements in symptoms or signs. For BCM, omega-3 does not repair cones, but it may help dry eye comfort in some cases.
Dosage: Product-dependent; discuss with a clinician if you have bleeding risk.
Function: Tear film and inflammation modulation (possible).
Mechanism: May affect inflammatory pathways and meibomian gland oil quality. [Cochrane omega-3 dry eye]

9) Riboflavin (Vitamin B2)

Long description: Riboflavin is important for energy metabolism. It is sometimes discussed for migraine support, which can overlap with light sensitivity in some people, though BCM light sensitivity is eye-based.
Dosage: Common supplement doses vary; avoid excess without guidance.
Function: Cellular energy support.
Mechanism: Supports mitochondrial enzyme function in cells. [NCCIH eye supplements science]

10) N-acetylcysteine (NAC) (use with medical advice)

Long description: NAC is an antioxidant precursor that supports glutathione pathways. Eye-specific benefits are not proven for BCM, but some people use NAC for general oxidative stress support.
Dosage: Varies by product; discuss safety and interactions first.
Function: Antioxidant pathway support.
Mechanism: Supports glutathione production, a key cellular antioxidant. [NCCIH eye supplements science]

---

Immunity booster / regenerative / stem-cell” drugs

For BCM, there are no approved “immunity booster” drugs, no approved regenerative drugs, and no approved stem-cell drugs that restore missing L/M cone function. What exists today is research and clinical-trial work. The items below are investigational approaches, not home treatments. [UIowa BCM gene augmentation/editing]

1) AAV-based gene augmentation for opsin delivery (investigational)

Long description: Many BCM research programs focus on delivering a working opsin gene to cones using an adeno-associated virus (AAV) vector. This is done by injection into or near the retina under specialist care. Animal studies show proof-of-concept for improving cone signals.
Dosage: Trial-specific (not a standard dose).
Function: Attempt to restore missing cone protein.
Mechanism: Adds a functional gene so cells can make the missing opsin. [Mouse gene augmentation proof]

2) Gene editing approaches (investigational)

Long description: Gene editing tries to correct the harmful genetic change instead of adding a new copy. This is complex and must be very precise in the retina. It is research-level today.
Dosage: Trial-specific.
Function: Correct underlying mutation (goal).
Mechanism: Edits DNA sequences in target retinal cells (research). [UIowa BCM case discussion]

3) Intravitreal gene therapy development programs (investigational)

Long description: Some programs study whether safer delivery routes (like intravitreal injection) can reach cones well enough. These are preclinical/early development questions and not routine care.
Dosage: Program-specific.
Function: Improve delivery safety and reach.
Mechanism: Uses vector design and promoters to target cone cells. [Adverum BCM preclinical PDF]

4) Stem-cell retinal cell approaches (general retinal research, not BCM-approved)

Long description: Stem-cell therapies are being explored in many retinal diseases to replace or support retinal cells. For BCM, cone-specific integration is very challenging and not a standard therapy today.
Dosage: Trial-specific.
Function: Cell support/replacement concept.
Mechanism: Attempts to introduce new cells or supportive factors (research). [BCM gene therapy review]

5) Neuroprotective “retinal support” strategies (investigational concept)

Long description: Some researchers look at ways to keep cones healthier for longer (neuroprotection). This might matter if a person has progressive macular changes. This is still a concept area rather than an approved drug plan for BCM.
Dosage: Not established.
Function: Preserve remaining retinal structure.
Mechanism: Reduces stress pathways that can damage cells. [PLOS BCM structure/function]

6) Enrollment in structured clinical studies (the practical “regenerative path” today)

Long description: Right now, the realistic way to access regenerative options is through carefully monitored studies. Trials list requirements, safety rules, and outcome testing. A retina genetics clinic can guide safe participation.
Dosage: Determined by the study protocol.
Function: Access to investigational therapy and monitoring.
Mechanism: Research protocol delivers therapy and measures changes with validated tests. [ClinicalTrials.gov study listing]

---

Surgeries (procedures, and why they are done)

Surgery does not cure BCM, but some people may need surgery for related eye problems that can happen in anyone, or for specific functional issues like eye alignment. [Cone dysfunction syndromes review]

1. Strabismus surgery (eye alignment surgery)
   Why it’s done: If eyes are misaligned and this affects function, comfort, or appearance, alignment surgery may help. It does not restore color vision, but it can improve coordination and sometimes reduce abnormal head posture. [Cone dysfunction syndromes review]

2. Nystagmus surgery (selected cases)
   Why it’s done: Some people adopt a head turn to find a “quiet point” where eyes shake less. In selected cases, surgery can shift that quiet point and reduce the head turn, improving comfort. This is specialist-dependent. [Cone dysfunction syndromes review]

3. Cataract surgery (if cataract develops)
   Why it’s done: Cataract makes vision more cloudy and increases glare. Removing cataract can improve clarity and reduce glare, which can be valuable when you already have low vision from BCM. Post-op anti-inflammatory drops are commonly used. [ACULAR label (post-cataract use)]

4. Retina surgery for unrelated retinal complications (rare, case-based)
   Why it’s done: BCM itself does not usually need retinal surgery, but if another retinal condition occurs (like retinal detachment), surgery may be needed to protect remaining vision. [PLOS BCM structure/function]

5. Punctal plug procedure (office procedure; sometimes grouped with “minor surgery”)
   Why it’s done: If severe dry eye adds pain and light sensitivity, punctal plugs can help keep tears on the eye longer. This is a common dry-eye procedure, not a BCM cure. [RESTASIS label context on dry eye care]

---

Prevention tips

1. Use glare protection every day (tints, hat, wrap frames) to prevent constant squinting and discomfort. [Tinted lenses therapeutic review]

2. Avoid direct midday sun exposure when possible; choose shade and timing. [Tinted lenses photophobia]

3. Keep dry eye controlled (blinking breaks, screen habits, clinician-guided care). [XIIDRA label]

4. Treat allergies early so rubbing and irritation do not worsen symptoms. [PATADAY label]

5. Do not self-start steroid drops (they can raise eye pressure and worsen infections). [PRED FORTE label]

6. Seek fast care for redness with pain/discharge (infection needs correct antibiotics). [VIGAMOX label]

7. Use safe study setups: larger font, controlled lighting, anti-glare screens. [Vision rehabilitation practice PDF]

8. Keep regular eye exams for refraction updates and retina monitoring. [PLOS BCM visual function]

9. Use non-color coding for safety (wires, chemicals, medications). [BCM gene therapy review]

10. If interested in future treatments, follow reputable trial channels with your retina specialist. [ClinicalTrials.gov BCM listing]

---

When to see a doctor (do not ignore these)

See an eye doctor soon if you have new strong pain, sudden vision drop, new flashes/floaters, or a “curtain” effect in vision. These can signal urgent problems not caused by BCM alone. [PLOS BCM structure/function]

See a doctor if you have red eye with discharge, crusting, or swelling, because bacterial infection may need prescription antibiotics and monitoring. [BESIVANCE label]

See a doctor before using any steroid eye drop, because steroids can raise eye pressure and can worsen certain infections if misused. [PRED FORTE label]

---

What to eat and what to avoid

1. Eat leafy greens (spinach, kale) for natural lutein/zeaxanthin sources. [Retina lutein/zeaxanthin review]

2. Eat colorful vegetables (orange/yellow) for carotenoids, but avoid high-dose vitamin A pills unless prescribed. [NIH ODS Vitamin A fact sheet]

3. Eat fish (or discuss omega-3 if you have dry eye), understanding benefits can be modest. [Cochrane omega-3 dry eye]

4. Eat nuts and seeds (vitamin E sources) in normal food amounts. [NEI AREDS/AREDS2 info]

5. Eat fruits (vitamin C sources) for general antioxidant support. [NEI AREDS/AREDS2 info]

6. Drink enough water to support comfort and tear film. [Vision rehabilitation practice PDF]

7. Avoid smoking (smoke increases oxidative stress and can harm eye health overall). [NEI AREDS/AREDS2 info]

8. Avoid unproven “mega supplement stacks” marketed as cures for genetic blindness. [NCCIH eye supplements science]

9. Avoid excess alcohol if it disrupts sleep and hydration, which can worsen eye discomfort. [NCCIH eye supplements science]

10. Avoid long screen sessions without breaks; food cannot replace good visual habits. [Vision rehabilitation practice PDF]

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: March 02, 2025.